Low levels of vitamin D may worsen leukemia
The findings result from a study of 390 chronic lymphocytic leukemia (CLL) patients, 30 percent of whom had insufficient vitamin D levels (less than 25 nanograms per milliliter) at the time of cancer diagnosis.
After a median follow-up of three years, patients with insufficient vitamin D levels were 66 percent more likely to have disease progression and to require chemotherapy. They also had a twofold increased risk of death, compared to those with adequate vitamin D levels.
The study also found that increasing vitamin D levels in patients was linked to longer survival times, even after controlling for other factors associated with leukemia progression.
Similar findings were seen in a different group of CLL patients who were followed for 10 years, according to the researchers at the Mayo Clinic in Rochester, Minnesota and the University of Iowa.
"This tells us that vitamin D insufficiency may be the first potentially modifiable risk factor associated with prognosis in newly diagnosed CLL," said study author and hematologist Dr Tait Shanafelt of the Mayo Clinic.
This is an important finding for both patients and doctors, the researchers said; Kazinform cites China Daily.
See www.chinadaily.com.cn for full version.